A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Surmodics Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 7,623 shares of SRDX stock, worth $301,413. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,623
Previous 6,508 17.13%
Holding current value
$301,413
Previous $273,000 8.06%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$38.47 - $42.24 $42,894 - $47,097
1,115 Added 17.13%
7,623 $295,000
Q2 2024

Aug 14, 2024

BUY
$25.39 - $42.1 $165,238 - $273,986
6,508 New
6,508 $273,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $554M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.